Updated

Scientists found that blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, pointing to a potential new treatment strategy for a range of neurological and psychiatric disorders. The discovery could enable repurposing of existing drugs for conditions including traumatic brain injury, Alzheimer's, Parkinson's, depression, and schizophrenia.